Medical device safety and product recalls were hot topics in October, with news of the US Food and Drug Administration reclassifying surgical staplers from low-risk class I to moderate-risk class II being the most-read story for Medtech Insight readers.
The FDA proposed reclassifying the staplers in 2019 after reviewing reports of more than 40,000 adverse events related to the...